Barclays Cuts Veeva Systems (NYSE:VEEV) Price Target to $250.00

Veeva Systems (NYSE:VEEV) had its price objective decreased by Barclays from $305.00 to $250.00 in a research note released on Wednesday,Benzinga reports. Barclays currently has an overweight rating on the technology company’s stock.

Several other research firms also recently issued reports on VEEV. Robert W. Baird upped their price target on Veeva Systems from $314.00 to $319.00 and gave the stock an “outperform” rating in a research note on Friday, November 21st. JPMorgan Chase & Co. decreased their target price on Veeva Systems from $330.00 to $296.00 and set an “overweight” rating for the company in a research report on Friday, February 20th. Citigroup lowered their price target on Veeva Systems from $349.00 to $319.00 and set a “buy” rating on the stock in a report on Monday, November 24th. BTIG Research restated a “buy” rating and issued a $340.00 price objective on shares of Veeva Systems in a research note on Friday, November 21st. Finally, The Goldman Sachs Group began coverage on shares of Veeva Systems in a research note on Tuesday, January 13th. They issued a “sell” rating and a $215.00 target price on the stock. Eighteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $293.71.

Veeva Systems Trading Down 0.6%

Shares of NYSE:VEEV opened at $181.69 on Wednesday. The stock has a market capitalization of $29.87 billion, a PE ratio of 35.35, a P/E/G ratio of 1.27 and a beta of 1.08. Veeva Systems has a 1 year low of $168.13 and a 1 year high of $310.50. The firm has a fifty day moving average price of $206.88 and a 200 day moving average price of $250.51.

Veeva Systems declared that its board has approved a stock buyback plan on Monday, January 5th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the technology company to purchase up to 5.5% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board of directors believes its shares are undervalued.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of the firm’s stock in a transaction on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total value of $231,430.00. Following the sale, the insider directly owned 23,204 shares in the company, valued at $5,370,101.72. This trade represents a 4.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 10.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Veeva Systems

Hedge funds have recently made changes to their positions in the stock. GPS Wealth Strategies Group LLC increased its stake in Veeva Systems by 196.4% during the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock valued at $25,000 after acquiring an additional 55 shares during the period. Board of the Pension Protection Fund bought a new stake in shares of Veeva Systems in the 4th quarter worth approximately $27,000. Raiffeisen Bank International AG acquired a new stake in shares of Veeva Systems during the 3rd quarter worth approximately $28,000. Newbridge Financial Services Group Inc. increased its position in shares of Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 100 shares during the period. Finally, Activest Wealth Management raised its stake in shares of Veeva Systems by 3,175.0% in the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 127 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced eSource, a product to streamline clinical-trial data capture and workflows — a strategic product that could accelerate adoption among pharma clients and support future subscription/solutions revenue growth. Veeva eSource launch
• Positive Sentiment: A broader software bounce after comments from Nvidia’s CEO easing AI cannibalization fears lifted enterprise software stocks, giving Veeva an intra-day boost as investors rotated back into high-quality SaaS names. Sector bounce after Nvidia comments
• Positive Sentiment: Investor attention has refocused on a recently approved ~$2B share buyback and upward estimate revisions ahead of the quarter — both factors that can support valuation and near-term shareholder returns. Valuation, buyback and estimate revisions
• Neutral Sentiment: Analysis pieces digging into Q4 (fiscal) metrics and Wall Street expectations provide detail that could amplify volatility around the upcoming earnings release — useful for investors but neutral until results arrive. Zacks Q4 projections
• Neutral Sentiment: Veeva is a trending search topic and several “what to know” roundups are circulating — they increase visibility but are informational rather than directional. Zacks trending stock note
• Negative Sentiment: Barclays issued a pessimistic forecast for Veeva, which is weighing on investor sentiment and can mechanically pressure the stock and investor expectations. Barclays bearish forecast
• Negative Sentiment: Stifel Nicolaus sharply cut its price target (from $320 to $212) while keeping a buy rating — the large reduction signals lower upside expectations and likely contributed to selling pressure. Stifel price-target cut
• Negative Sentiment: Oppenheimer trimmed its price target to $275, another analyst hit that reduces headline upside and can sap momentum ahead of earnings. Oppenheimer price-target cut
• Negative Sentiment: Short interest rose about 26% in early February to ~6.33M shares (4.3% of float), increasing the potential for downward pressure and volatility if bearish sentiment persists.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.